Coronavirus cases in India cross 6 million

New Delhi, Sep 28 (efe-epa).- India surpassed the six million confirmed cases of coronavirus on Monday, while the death toll crossed the 95,000 mark.

The south Asian country has recorded a total of 6,074,703 cases of Covid-19, including 82,170 new infections and 1,039 fresh deaths in the last 24 hours, according to the latest data from the Indian Ministry of Health.

India is the country with the second highest caseload of coronavirus cases in the world, behind the United States, which has so far detected over 7.2 million cases.

The Indian authorities have been highlighting the relatively low mortality rate in the world’s second most populated country with 1.3 billion inhabitants.

The United States has more than twice as many deaths, amounting to some 205,000; whereas Brazil, with some 4.7 million cases, has recorded around 141,000 deaths.

However, experts and seroprevalence studies have warned that India’s actual figures could be much higher than officially accounted for.

While health authorities are expected to publish a new seroprevalence study, Health Minister Harsh Vardhan said on Sunday that India has not yet achieved herd immunity against the coronavirus.

“Indian population is still far from achieving herd immunity against Covid-19,” Vardhan said during an interaction with the media.

India has been recording the highest number of new cases in the world since August.

In September, India recorded an average of 90,000 cases per day until recently, raising fears that it would overtake the US within a few weeks.

India, one of the largest vaccine producers in the world, has pledged to use this capacity “to help all humanity,” according to an address made by the country’s Prime Minister Narendra Modi before the United Nations during the weekend.

Before the UN, the south Asian country promised to help other countries improve their cold storage capacity to facilitate the supply of vaccines, while also questioning the international body’s response to the pandemic.

India is already on the final phase of trials of several vaccines, including one by AstraZeneca in collaboration with the country’s Serum Institute, one of the largest manufacturers of vaccines in the world. EFE-EPA


Related Articles

Back to top button